<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00724113</url>
  </required_header>
  <id_info>
    <org_study_id>P051039</org_study_id>
    <nct_id>NCT00724113</nct_id>
  </id_info>
  <brief_title>ARTHRO Distension Plus Intensive Mobilisation in Shoulder Capsulitis</brief_title>
  <acronym>CAPSULITE</acronym>
  <official_title>Evaluation of the Effectiveness of ARTHRO -Distension Plus Intensive Mobilisation in Shoulder Capsulitis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Assistance Publique - Hôpitaux de Paris</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Assistance Publique - Hôpitaux de Paris</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to evaluate the effectiveness of ARTHRO distension plus
      intensive mobilisation in shoulder capsulitis.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The aim of the study is to evaluate a treatment of shoulder capsulitis that associates ARTHRO
      distension and intensive mobilisation at 2, 6, 12, 26 and 52 weeks. It is a bicentric
      87-month (inclusion: 74 months; follow up: 13 months) observer blind randomised clinical
      trial using 2 groups in parallel. The number of patients to be included is 66. The treatment
      that is evaluated associates ARTHRO distension followed by mobilisation of the shoulder 6
      hours per day during 5 days, and then sessions of physiotherapy for 4 weeks. The control
      intervention is one intra-articular injection of corticosteroids and physiotherapy. The
      primary outcome is SPADI, namely pain and disability, at 2 weeks.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>February 2009</start_date>
  <completion_date type="Actual">July 2014</completion_date>
  <primary_completion_date type="Actual">August 2013</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Pain and disability using SPADI score at 2 weeks</measure>
    <time_frame>at 2 weeks</time_frame>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">66</enrollment>
  <condition>Shoulder Capsulitis</condition>
  <arm_group>
    <arm_group_label>1</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>infiltration intra articular</description>
  </arm_group>
  <arm_group>
    <arm_group_label>2</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>ARTHRO distension plus intensive mobilisation</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>infiltration intra articular</intervention_name>
    <description>infiltration intra articular at inclusion with XYLOCAINE 1%</description>
    <arm_group_label>1</arm_group_label>
    <other_name>infiltration intra articular at inclusion with XYLOCAINE 1%</other_name>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>ARTHRO distension plus intensive mobilisation</intervention_name>
    <description>ARTHRO distension plus intensive mobilisation</description>
    <arm_group_label>2</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  age ≥ 18 years

          -  shoulder capsulitis

          -  duration of symptoms ≥ 3 months

          -  health insurance

        Exclusion Criteria:

          -  cognitive disorders

          -  Hypo coagulation

          -  biological inflammatory syndrome

          -  uncontrolled diabetes

          -  XYLOCAINE allergy

          -  pregnancy

          -  unable to understand and to speak french

          -  previous surgery of shoulder

          -  shoulder infiltration or distension in the previous month

          -  local contraindication to shoulder infiltration
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Johann Beaudreuil, PH MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Assistance Publique - Hôpitaux de Paris</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Rheumatology department of Lariboisiere hospital</name>
      <address>
        <city>Paris</city>
        <zip>75010</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>May 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 9, 2008</study_first_submitted>
  <study_first_submitted_qc>July 28, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 29, 2008</study_first_posted>
  <last_update_submitted>January 3, 2017</last_update_submitted>
  <last_update_submitted_qc>January 3, 2017</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 4, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Shoulder capsulitis</keyword>
  <keyword>ARTHRO distension</keyword>
  <keyword>Mobilisation</keyword>
  <keyword>Randomised clinical trial</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Bursitis</mesh_term>
    <mesh_term>Dilatation, Pathologic</mesh_term>
    <mesh_term>Periarthritis</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Lidocaine</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

